litlas
ログインアカウント作成

William D. Figg

1994–2025 年に発表

別表記
William D Figg
269
論文数
39,164
被引用数
119
h 指数
263
i10 指数

被引用数

William D. Figg の年別被引用数1987 年: 被引用 1 件1989 年: 被引用 1 件1992 年: 被引用 1 件1993 年: 被引用 1 件1994 年: 被引用 1 件1995 年: 被引用 12 件1996 年: 被引用 10 件1997 年: 被引用 34 件1998 年: 被引用 35 件1999 年: 被引用 53 件2000 年: 被引用 102 件2001 年: 被引用 148 件2002 年: 被引用 179 件2003 年: 被引用 210 件2004 年: 被引用 295 件2005 年: 被引用 287 件2006 年: 被引用 296 件2007 年: 被引用 308 件2008 年: 被引用 339 件2009 年: 被引用 389 件2010 年: 被引用 349 件2011 年: 被引用 451 件2012 年: 被引用 350 件2013 年: 被引用 346 件2014 年: 被引用 317 件2015 年: 被引用 330 件2016 年: 被引用 268 件2017 年: 被引用 328 件2018 年: 被引用 288 件2019 年: 被引用 897 件2020 年: 被引用 1,115 件2021 年: 被引用 1,187 件2022 年: 被引用 911 件2023 年: 被引用 745 件2024 年: 被引用 1,093 件2025 年: 被引用 563 件2026 年: 被引用 7 件1988 年は被引用が無いため表示していません1990〜1991 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 4,981 件、この内訳の 30.7%中国: 引用元論文 1,706 件、この内訳の 10.5%イギリス: 引用元論文 950 件、この内訳の 5.9%イタリア: 引用元論文 798 件、この内訳の 4.9%ドイツ: 引用元論文 765 件、この内訳の 4.7%フランス: 引用元論文 564 件、この内訳の 3.5%カナダ: 引用元論文 540 件、この内訳の 3.3%日本: 引用元論文 493 件、この内訳の 3%オランダ: 引用元論文 419 件、この内訳の 2.6%スペイン: 引用元論文 404 件、この内訳の 2.5%オーストラリア: 引用元論文 377 件、この内訳の 2.3%インド: 引用元論文 368 件、この内訳の 2.3%
0%30.7%その他 23.8%

機関

分野

  • Medicine54.9%
  • Biochemistry, Genetics and Molecular Biology29.5%
  • Immunology and Microbiology5.5%
  • Pharmacology, Toxicology and Pharmaceutics2.4%
  • Materials Science1.8%
  • Engineering1.1%
  • その他4.8%

トピック

  • Prostate Cancer Treatment and Research3.7%
  • Cancer Immunotherapy and Biomarkers2.7%
  • Histone Deacetylase Inhibitors Research2.4%
  • Prostate Cancer Diagnosis and Treatment2%
  • CAR-T cell therapy research1.9%
  • Protein Degradation and Inhibitors1.9%
  • その他85.4%

共著者

全論文

検索で開く
  1. Antibody–drug conjugates for cancer

    著者: Cindy H. Chau, Patricia S. Steeg, William D. Figg - The Lancet 2019 被引用: 790

  2. Selumetinib in Children with Inoperable Plexiform Neurofibromas

    著者: Andrea M. Gross, Pamela L. Wolters, Eva Dombi, Andrea Baldwin, Patricia Whitcomb, Michael J. Fisher, Brian Weiss, AeRang Kim, Miriam Bornhorst, Amish C. Shah, Staci Martin, Marie Claire Roderick, Dominique C. Pichard, Amanda Carbonell, Scott M. Paul, Janet Therrien, Oxana B. Kapustina, Kara Heisey, D. Wade Clapp, Chi Zhang, Cody J. Peer, William D. Figg, Malcolm A. Smith, John Glod, Jaishri O. Blakeley, Seth M. Steinberg, David Venzon, L. Austin Doyle, Brigitte C. Widemann - New England Journal of Medicine 2020 被引用: 698

  3. Tremelimumab in combination with ablation in patients with advanced hepatocellular carcinoma

    著者: Austin G. Duffy, Susanna V. Ulahannan, Oxana Makorova-Rusher, Osama E. Rahma, Heiner Wedemeyer, Drew Pratt, Jeremy L. Davis, Marybeth S. Hughes, Theo Heller, Mei ElGindi, Ashish Uppala, Firouzeh Korangy, David E. Kleiner, William D. Figg, David Venzon, Seth M. Steinberg, Aradhana M. Venkatesan, Venkatesh Krishnasamy, Nadine Abi‐Jaoudeh, Elliot Levy, Bradford J. Wood, Tim F. Greten - Journal of Hepatology 2016 被引用: 818

  4. Redistribution, Hyperproliferation, Activation of Natural Killer Cells and CD8 T Cells, and Cytokine Production During First-in-Human Clinical Trial of Recombinant Human Interleukin-15 in Patients With Cancer

    著者: Kevin C. Conlon, Enrico Lugli, Hugh C. Welles, Steven A. Rosenberg, Antonio Tito Fojo, John C. Morris, Thomas A. Fleisher, Sigrid Dubois, Liyanage P. Perera, Donn M. Stewart, Carolyn K. Goldman, Bonita R. Bryant, Jean M. Decker, Jing Chen, Tatyana Worthy, William D. Figg, Cody J. Peer, Michael C. Sneller, H. Clifford Lane, Jason L. Yovandich, Stephen P. Creekmore, Mario Roederer, Thomas A. Waldmann - Journal of Clinical Oncology 2014 被引用: 702

  5. Design and End Points of Clinical Trials for Patients With Progressive Prostate Cancer and Castrate Levels of Testosterone: Recommendations of the Prostate Cancer Clinical Trials Working Group

    著者: Howard I. Scher, Susan Halabi, Ian F. Tannock, Michael J. Morris, Cora N. Sternberg, Michael A. Carducci, Mario A. Eisenberger, Celestia S. Higano, Glenn J. Bubley, Robert Dreicer, Daniel Petrylak, Philip W. Kantoff, Ethan Basch, William Kevin Kelly, William D. Figg, Eric J. Small, Tomasz M. Beer, George Wilding, Alison Martin, Maha Hussain - Journal of Clinical Oncology 2008 被引用: 2,241

  6. Liquid biopsy epigenomic profiling for cancer subtyping

    著者: Sylvan C. Baca, Ji-Heui Seo, Matthew P. Davidsohn, Brad Fortunato, Karl Semaan, Shahabbedin Sotudian, Gitanjali Lakshminarayanan, Miklós Dióssy, Xintao Qiu, Talal El Zarif, Hunter Savignano, John Canniff, Ikenna Madueke, Renée Maria Saliby, Ziwei Zhang, Rong Li, Yijia Jiang, Len Taing, Mark M. Awad, Cindy H. Chau, James A. DeCaprio, William D. Figg, Tim F. Greten, Aaron N. Hata, F. Stephen Hodi, Melissa E. Hughes, Keith L. Ligon, Nancy U. Lin, Kimmie Ng, Matthew G. Oser, Catherine B. Meador, Heather A. Parsons, Mark M. Pomerantz, Arun Rajan, Jerome Ritz, Manisha Thakuria, Sara M. Tolaney, Patrick Y. Wen, Henry W. Long, Jacob E. Berchuck, Zoltán Szállási, Toni K. Choueiri, Matthew L. Freedman - Nature Medicine 2023 被引用: 118

  7. Therapeutic targeting of ATR yields durable regressions in small cell lung cancers with high replication stress

    著者: Anish Thomas, Nobuyuki Takahashi, Vinodh N. Rajapakse, Xiaohu Zhang, Yilun Sun, Michele Ceribelli, Kelli M. Wilson, Yang Zhang, Erin Beck, Linda Sciuto, Samantha Nichols, Brian Elenbaas, Janusz Puc, Heike Dahmen, Astrid Zimmermann, Jillian Varonin, Christopher W. Schultz, Se Hyun Kim, Hirity Shimellis, Parth Desai, Carleen Klumpp‐Thomas, Lu Chen, Jameson Travers, Crystal McKnight, Sam Michael, Zina Itkin, Sunmin Lee, Akira Yuno, Min-Jung Lee, Christophe E. Redon, Jessica D. Kindrick, Cody J. Peer, Jun S. Wei, Mirit I. Aladjem, William D. Figg, Seth M. Steinberg, Jane B. Trepel, Frank T. Zenke, Yves Pommier, Javed Khan, Craig J. Thomas - Cancer Cell 2021 被引用: 177

  8. Alterations of human skin microbiome and expansion of antimicrobial resistance after systemic antibiotics

    著者: Jay‐Hyun Jo, Catriona P. Harkins, Nicole H. Schwardt, J. Portillo, NISC Comparative Sequencing Program, Matthew Zimmerman, Claire L. Carter, Md Amir Hossen, Cody J. Peer, Eric C. Polley, Véronique Dartois, William D. Figg, Niki M. Moutsopoulos, Julia A. Segre, Heidi H. Kong - Science Translational Medicine 2021 被引用: 111

  9. Thalidomide

    著者: Michael Franks, Gordon R. Macpherson, William D. Figg - The Lancet 2004 被引用: 603

  10. Phase I/II study of PexaVec in combination with immune checkpoint inhibition in refractory metastatic colorectal cancer

    著者: Cecilia Monge, Changqing Xie, Yuta Myojin, Kelley Coffman, Donna Mabry Hrones, Sophie Wang, Jonathan M. Hernandez, Bradford J. Wood, Elliot Levy, Israa Juburi, Stephen M. Hewitt, David E. Kleiner, Seth M. Steinberg, William D. Figg, Bernadette Redd, Philip Homan, Maggie Cam, Benjamin Ruf, Austin G. Duffy, Tim F. Greten - Journal for ImmunoTherapy of Cancer 2023 被引用: 71

  11. Resistance to second-generation androgen receptor antagonists in prostate cancer

    著者: Keith T. Schmidt, Alwin D. R. Huitema, Cindy H. Chau, William D. Figg - Nature Reviews Urology 2021 被引用: 128

  12. IL15 by Continuous Intravenous Infusion to Adult Patients with Solid Tumors in a Phase I Trial Induced Dramatic NK-Cell Subset Expansion

    著者: Kevin C. Conlon, E. Lake Potter, Stefania Pittaluga, Chyi‐Chia Richard Lee, Miloš D. Miljković, Thomas A. Fleisher, Sigrid Dubois, Bonita R. Bryant, Michael Petrus, Liyanage P. Perera, Jennifer L. Hsu, William D. Figg, Cody J. Peer, Joanna H. Shih, Jason L. Yovandich, Stephen P. Creekmore, Mario Roederer, Thomas A. Waldmann - Clinical Cancer Research 2019 被引用: 133

  13. Phase II Multi-Institutional Trial of the Histone Deacetylase Inhibitor Romidepsin As Monotherapy for Patients With Cutaneous T-Cell Lymphoma

    著者: Richard Piekarz, Robin Frye, Maria L. Turner, John J. Wright, Steven L. Allen, Mark Kirschbaum, Jasmine Zain, H. Miles Prince, John P. Leonard, Larisa J. Geskin, Craig B. Reeder, David Joske, William D. Figg, Erin R. Gardner, Seth M. Steinberg, Elaine S. Jaffe, Maryalice Stetler‐Stevenson, Stephen Lade, Antonio Tito Fojo, Susan E. Bates - Journal of Clinical Oncology 2009 被引用: 737

  14. PARP inhibitors: A review of the pharmacology, pharmacokinetics, and pharmacogenetics

    著者: Yi Zeng, Oluwatobi Arisa, Cody J. Peer, Antonio Tito Fojo, William D. Figg - Seminars in Oncology 2023 被引用: 79

  15. Phase I Study of Cabozantinib and Nivolumab Alone or With Ipilimumab for Advanced or Metastatic Urothelial Carcinoma and Other Genitourinary Tumors

    著者: Andrea B. Apolo, Rosa Nadal, Daniel M. Girardi, Scot A. Niglio, Lisa Ley, Lisa M. Cordes, Seth M. Steinberg, Olena Sierra Ortiz, Jacqueline Cadena, Carlos Guerrero Díaz, Marissa Mallek, Nicole N. Davarpanah, Rene Costello, Jane B. Trepel, Min-Jung Lee, Maria J. Merino, Mohammadhadi Bagheri, Paul Monk, William D. Figg, James L. Gulley, Piyush K. Agarwal, Vladimir Valera, Heather J. Chalfin, Jennifer Jones, Howard Streicher, John J. Wright, Yang‐Min Ning, Howard L. Parnes, William L. Dahut, Donald P. Bottaro, Primo N. Lara, Biren Saraiya, Sumanta K. Pal, Mark N. Stein, Amir Mortazavi - Journal of Clinical Oncology 2020 被引用: 137

  16. Comparative Preclinical and Clinical Pharmacokinetics of a Cremophor-Free, Nanoparticle Albumin-Bound Paclitaxel (ABI-007) and Paclitaxel Formulated in Cremophor (Taxol)

    著者: Alex Sparreboom, Charity D. Scripture, Vuong Trieu, Paul J. Williams, Tapas De, Andrew Yang, Bridget Beals, William D. Figg, Michael Hawkins, Neil Desai - Clinical Cancer Research 2005 被引用: 496

  17. Safety and Clinical Activity of the Programmed Death-Ligand 1 Inhibitor Durvalumab in Combination With Poly (ADP-Ribose) Polymerase Inhibitor Olaparib or Vascular Endothelial Growth Factor Receptor 1-3 Inhibitor Cediranib in Women's Cancers: A Dose-Escalation, Phase I Study

    著者: Jung Min Lee, Ashley Cimino‐Mathews, Cody J. Peer, Alexandra S. Zimmer, Stanley Lipkowitz, Christina M. Annunziata, Liang Cao, Maria I. Harrell, Elizabeth M. Swisher, Nicole Houston, Dana‐Adriana Botesteanu, Janis M. Taube, Elizabeth Thompson, Aleksandra Ogurtsova, Haiying Xu, Jeffers Nguyen, Tony W. Ho, William D. Figg, Elise C. Kohn - Journal of Clinical Oncology 2017 被引用: 240

  18. Phase I trial of panobinostat in children with diffuse intrinsic pontine glioma: A report from the Pediatric Brain Tumor Consortium (PBTC-047)

    著者: Michelle Monje, Tabitha Cooney, John Glod, Jie Huang, Cody J. Peer, Damien Faury, Patricia Baxter, Kim Kramer, Alicia Lenzen, Nathan Robison, Lindsay Kilburn, Anna Vinitsky, William D. Figg, Nada Jabado, Maryam Fouladi, Jason Fangusaro, Arzu Onar‐Thomas, Ira J. Dunkel, Katherine E Warren - Neuro-Oncology 2023 被引用: 63

  19. PARP Inhibitors and Prostate Cancer: To Infinity and BeyondBRCA

    著者: Emily N. Risdon, Cindy H. Chau, Douglas K. Price, Oliver Sartor, William D. Figg - The Oncologist 2020 被引用: 97

  20. Inhibition of p38α MAPK restores neuronal p38γ MAPK and ameliorates synaptic degeneration in a mouse model of DLB/PD

    著者: Michiyo Iba, Changyoun Kim, Somin Kwon, Marcell Szabo, Liam Horan-Portelance, Cody J. Peer, William D. Figg, Xylena Reed, Jinhui Ding, Seung‐Jae Lee, Robert A. Rissman, Mark Cookson, Cassia Overk, Wolf Wrasidlo, Eliezer Masliah - Science Translational Medicine 2023 被引用: 40

  21. Lack of activity of recombinant HIF prolyl hydroxylases (PHDs) on reported non-HIF substrates

    著者: Matthew E. Cockman, Kerstin Lippl, Ya‐Min Tian, Hamish B. Pegg, William D. Figg, Martine I. Abboud, Raphael Heilig, Román Fischer, Johanna Myllyharju, Christopher J. Schofield, Peter J. Ratcliffe - eLife 2019 被引用: 105

  22. Safety (toxicity), pharmacokinetics, immunogenicity, and impact on elements of the normal immune system of recombinant human IL-15 in rhesus macaques

    著者: Thomas A. Waldmann, Enrico Lugli, Mario Roederer, Liyanage P. Perera, Jeremy Smedley, Rhonda MacAllister, Carolyn K. Goldman, Bonita R. Bryant, Jean M. Decker, Thomas A. Fleisher, H. Clifford Lane, Michael C. Sneller, Roger Kurlander, David E. Kleiner, J. M. Pletcher, William D. Figg, Jason L. Yovandich, Stephen P. Creekmore - Blood 2011 被引用: 194

  23. The effect of anti-CTLA4 treatment on peripheral and intra-tumoral T cells in patients with hepatocellular carcinoma

    著者: David Agdashian, Mei ElGindi, Changqing Xie, Milan Sandhu, Drew Pratt, David E. Kleiner, William D. Figg, Julie Rytlewski, Catherine Sanders, Erik Yusko, Bradford J. Wood, David Venzon, Gagandeep Brar, Austin G. Duffy, Tim F. Greten, Firouzeh Korangy - Cancer Immunology Immunotherapy 2019 被引用: 171

  24. Exosome is a mechanism of intercellular drug transfer: Application of quantitative pharmacology

    著者: Jin Wang, Bertrand Z. Yeung, Minjian Cui, Cody J. Peer, Ze Lu, William D. Figg, M. Guillaume Wientjes, Sukyung Woo, Jessie L.‐S. Au - Journal of Controlled Release 2017 被引用: 85